NCT05198869View on ClinicalTrials.gov

SpotLight-19 Research & Development Study

NAUnknownINTERVENTIONAL
Enrollment

12,500

Participants

Timeline

Start Date

December 29, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

July 31, 2022

Conditions
Screening
Interventions
DEVICE

Spectral scan

Consenting participants will have a SpotLight-19 scan

Trial Locations (2)

K1S 5T1

NOT_YET_RECRUITING

COVID-19 CHEO Assessment Centre, Ottawa

K1S5T1

RECRUITING

COVID-19 Assessment Centre for Adults, Ottawa

Sponsors
All Listed Sponsors
collaborator

ISBRG Corp

OTHER

lead

Ottawa Hospital Research Institute

OTHER